Molecular characterization of the boron adducts of the proteasome inhibitor bortezomib with epigallocatechin-3-gallate and related polyphenols
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular characterization of the boron adducts of the proteasome inhibitor bortezomib with epigallocatechin-3-gallate and related polyphenols
Authors
Keywords
-
Journal
ORGANIC & BIOMOLECULAR CHEMISTRY
Volume 13, Issue 13, Pages 3887-3899
Publisher
Royal Society of Chemistry (RSC)
Online
2015-01-30
DOI
10.1039/c4ob02512a
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate
- (2014) Sabita N. Saldanha et al. EXPERIMENTAL CELL RESEARCH
- Liposomal Bortezomib Nanoparticles via Boronic Ester Prodrug Formulation for Improved Therapeutic Efficacy in Vivo
- (2014) Jonathan D. Ashley et al. JOURNAL OF MEDICINAL CHEMISTRY
- 19F NMR monitoring of the eukaryotic 20S proteasome chymotrypsin-like activity: an investigative tool for studying allosteric regulation
- (2014) M. Keita et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- 19F NMR: a valuable tool for studying biological events
- (2013) Han Chen et al. CHEMICAL SOCIETY REVIEWS
- Potential for preventive effects of cocoa and cocoa polyphenols in cancer
- (2013) Maria Angeles Martin et al. FOOD AND CHEMICAL TOXICOLOGY
- Substituent Effects and pH Profiles for Stability Constants of Arylboronic Acid Diol Esters
- (2013) Mayte A. Martínez-Aguirre et al. JOURNAL OF ORGANIC CHEMISTRY
- Endoplasmic Reticulum Stress and the Unfolded Protein Response: Targeting the Achilles Heel of Multiple Myeloma
- (2013) L. Vincenz et al. MOLECULAR CANCER THERAPEUTICS
- Dietary phytochemicals in cancer prevention and therapy: a complementary approach with promising perspectives
- (2013) Margarita González-Vallinas et al. NUTRITION REVIEWS
- Targeting Tumor Ubiquitin-Proteasome Pathway with Polyphenols for Chemosensitization
- (2012) Min Shen et al. Anti-Cancer Agents in Medicinal Chemistry
- Preferential killing of triple-negative breast cancer cells in vitro and in vivo when pharmacological aggravators of endoplasmic reticulum stress are combined with autophagy inhibitors
- (2012) Simmy Thomas et al. CANCER LETTERS
- Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent
- (2012) Natasha Sharma et al. CANCER LETTERS
- Boron Containing Compounds as Protease Inhibitors
- (2012) Reem Smoum et al. CHEMICAL REVIEWS
- Perillyl Alcohol for the Treatment of Temozolomide-Resistant Gliomas
- (2012) H.-Y. Cho et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2
- (2012) Nimanthi Jayathilaka et al. NUCLEIC ACIDS RESEARCH
- Cocoa Polyphenols and Their Potential Benefits for Human Health
- (2012) I. Andújar et al. Oxidative Medicine and Cellular Longevity
- Therapeutic targeting of cancer cell cycle using proteasome inhibitors
- (2012) Namrata Rastogi et al. Cell Division
- Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea
- (2011) Bret Bannerman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Enhancement of photodynamic therapy by 2,5-dimethyl celecoxib, a non-cyclooxygenase-2 inhibitor analog of celecoxib
- (2011) Angela Ferrario et al. CANCER LETTERS
- Boron-containing inhibitors of synthetases
- (2011) Stephen J. Baker et al. CHEMICAL SOCIETY REVIEWS
- Preclinical Development of Novel Anti-Glioma Drugs Targeting the Endoplasmic Reticulum Stress Response
- (2011) Axel H. Schonthal et al. CURRENT PHARMACEUTICAL DESIGN
- Novel, orally active, proteasome inhibitor, delanzomib (CEP-18770), ameliorates disease symptoms and glomerulonephritis in two preclinical mouse models of SLE
- (2011) Matthew M. Seavey et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Catechol Polymers for pH-Responsive, Targeted Drug Delivery to Cancer Cells
- (2011) Jing Su et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Inhibitory effect of bortezomib on human multiple myeloma cells when combined with epigallocatechin-gallate (EGCG) analogs
- (2011) Sreedhar Pamu et al. MedChemComm
- Combination Therapy of Bortezomib with Novel Targeted Agents: An Emerging Treatment Strategy
- (2010) J. J. Wright CLINICAL CANCER RESEARCH
- Antiangiogenic Activities of 2,5-Dimethyl-Celecoxib on the Tumor Vasculature
- (2010) J. J. Virrey et al. MOLECULAR CANCER THERAPEUTICS
- Cancer Prevention With Natural Compounds
- (2010) Norleena P. Gullett et al. SEMINARS IN ONCOLOGY
- Boronic acids in medicinal chemistry: anticancer, antibacterial and antiviral applications
- (2010) Paul C. Trippier et al. MedChemComm
- Potentiation of (-)-epigallocatechin-3-gallate-induced apoptosis by bortezomib in multiple myeloma cells
- (2009) Q. Wang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Dimeric procyanidins are inhibitors of NF-κB–DNA binding
- (2009) Gerardo G. Mackenzie et al. BIOCHEMICAL PHARMACOLOGY
- Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors
- (2009) E. B. Golden et al. BLOOD
- Bortezomib induces canonical nuclear factor- B activation in multiple myeloma cells
- (2009) T. Hideshima et al. BLOOD
- Natural polyphenols antagonize the antimyeloma activity of proteasome inhibitor bortezomib by direct chemical interaction
- (2009) Tae Young Kim et al. BRITISH JOURNAL OF HAEMATOLOGY
- Enhanced killing of chemo-resistant breast cancer cells via controlled aggravation of ER stress
- (2009) Hee-Yeon Cho et al. CANCER LETTERS
- Bortezomib
- (2009) Monique P. Curran et al. DRUGS
- Design and NMR-Based Screening of LEF, a Library of Chemical Fragments with Different Local Environment of Fluorine
- (2009) Anna Vulpetti et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Ascorbic acid inhibits antitumor activity of bortezomib in vivo
- (2009) G Perrone et al. LEUKEMIA
- Cytotoxic effects of celecoxib on Raji lymphoma cells correlate with aggravated endoplasmic reticulum stress but not with inhibition of cyclooxygenase-2
- (2009) Szu-Ting Chen et al. LEUKEMIA RESEARCH
- Molecular mechanisms of proteasome assembly
- (2009) Shigeo Murata et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Molecular Mechanisms of Green Tea Polyphenols
- (2009) Q. Ping Dou NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Bortezomib: A novel chemotherapeutic agent for hematologic malignancies
- (2008) Kyle N. Utecht et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Pyrogallol and its analogs can antagonize bacterial quorum sensing in Vibrio harveyi
- (2008) Nanting Ni et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib
- (2008) F.-T. Liu et al. BLOOD
- Multitargeted therapy of cancer by green tea polyphenols
- (2008) Naghma Khan et al. CANCER LETTERS
- Aggravated Endoplasmic Reticulum Stress as a Basis for Enhanced Glioblastoma Cell Killing by Bortezomib in Combination with Celecoxib or Its Non-Coxib Analogue, 2,5-Dimethyl-Celecoxib
- (2008) A. Kardosh et al. CANCER RESEARCH
- Preferential Cytotoxicity of Bortezomib toward Hypoxic Tumor Cells via Overactivation of Endoplasmic Reticulum Stress Pathways
- (2008) D. R. Fels et al. CANCER RESEARCH
- Advances in and applications of proteasome inhibitors
- (2008) Bradley S Moore et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Safety of Green Tea Extracts
- (2008) Dandapantula N Sarma et al. DRUG SAFETY
- Celecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs
- (2008) Axel H Schönthal et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Discovery of a Potent, Selective, and Orally Active Proteasome Inhibitor for the Treatment of Cancer
- (2008) Bruce D. Dorsey et al. JOURNAL OF MEDICINAL CHEMISTRY
- COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro
- (2008) Huan-Ching Chuang et al. Molecular Cancer
- Green tea polyphenols as a natural tumour cell proteasome inhibitor
- (2008) Q. P. Dou et al. INFLAMMOPHARMACOLOGY
- Simple, Efficient, and Modular Syntheses of Polyene Natural Products via Iterative Cross-Coupling
- (2007) Suk Joong Lee et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search